Fermenta Biotech acquires land at Sayakha Industrial Estate as part of capacity expansion plans

S Singh
S Singh
· 2 min read

DIL Limited’s subsidiary, Fermenta Biotech Limited (FBL), a leading global manufacturer and supplier of Vitamin D3 (Cholecalciferol) has executed a 99 year lease agreement for acquisition of land aggregating to about 40,000 Sq M from the Gujarat Industrial Development Corporation (GIDC) authority, Ankleshwar, Sayakha, for future expansion and new projects.

The land acquisition is a part of the FBL’s long-term capacity expansion plans. The company aims to commence manufacturing by end of 2020. The existing Dahej facility is 30,689 Sq Meter. Prashant Nagre, Chief Executive Officer of FBL, commented on this new development,“The growing demand from customers across the world necessitated the scale up of our capacities, and Sayakha was our preferred choice to set up a new plant. We wish to continue our association with Gujarat and benefit from this investor friendly atmosphere. Sayakha is strategically located between Dahej and Bharuch and will generate synergies.

Strategically, Fermenta is positioning itself as a nutraceutical ingredients manufacturer, by entering into the nutrition vertical through not only value added variants of Vitamin D3, but also new products in the Vitamin and Mineral Supplements segment. Hence, our new plant at Sayakha is a step forward in growing organically in order to facilitate product extensions and new product rollouts.”

Read Next

Healthium MedTech Supports GIMS In Delivering Advanced Paediatric Orthopaedic Surgeries
News
May 8, 2026

Healthium MedTech Supports GIMS In Delivering Advanced Paediatric Orthopaedic Surgeries

The Government Institute of Medical Sciences (GIMS), Greater Noida, with support from Healthium MedTech’s CSR initiative and implemented by Plan International India Chapter, is now fully equipped to undertake advanced paediatric orthopaedic surgeries. In a major boost to child healthcare, the institute can now treat conditions such as developmental dysplasia of the hip (DDH), clubfoot, […]
Article by: IMT News Desk
Biocon Q4FY26 EBITDA jumps to Rs 1,073 crore; net profit before exceptional items up 64%
News
May 8, 2026

Biocon Q4FY26 EBITDA jumps to Rs 1,073 crore; net profit before exceptional items up 64%

Biocon Limited reported a consolidated total income of Rs 4,569 crore in Q4FY26, up 10% year-on-year on an adjusted basis, while EBITDA rose 29% to Rs 1,073 crore and net profit before exceptional items climbed 64% to Rs 179 crore. For the full year FY26, total income stood at Rs 17,270 crore, EBITDA at Rs […]
Article by: IMT News Desk
National Health Mission, Madhya Pradesh and Sanofi India sign MoU to strengthen public health service
News
May 8, 2026

National Health Mission, Madhya Pradesh and Sanofi India sign MoU to strengthen public health service

The National Health Mission Madhya Pradesh (NHM, MP) signed a Memorandum of Understanding (MoU) with Sanofi (India) to strengthen public health services within the state. The objective of this partnership is to raise awareness of Non-Communicable Diseases (NCDs), such as diabetes, to encourage early detection and treatment, and to provide support to people living with […]
Article by: IMT News Desk
RGCIRC Leads World Thalassemia Day Awareness Drive in Delhi
News
May 8, 2026

RGCIRC Leads World Thalassemia Day Awareness Drive in Delhi

RGCIRC (Rajiv Gandhi Cancer Institute & Research Centre) organised an awareness and screening initiative to address the rising burden of thalassemia in the National Capital Region. Held under the theme “From Transfusion to Transplant,” the event highlighted the need for a critical shift in thalassemia care – from lifelong dependence on blood transfusions to curative […]
Article by: IMT News Desk